Your browser doesn't support javascript.
loading
Impact of Kidney Disease on Peripheral Arterial Interventions: A Systematic Review and Meta-Analysis.
Anantha-Narayanan, Mahesh; Sheikh, Azfar Bilal; Nagpal, Sameer; Smolderen, Kim G; Turner, Jeffrey; Schneider, Marabel; Llanos-Chea, Fiorella; Mena-Hurtado, Carlos.
Afiliación
  • Anantha-Narayanan M; Section of Cardiovascular Diseases, Yale New Haven Hospital, New Haven, Connecticut, USA, manantha@umn.edu.
  • Sheikh AB; Section of Cardiovascular Diseases, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Nagpal S; Section of Cardiovascular Diseases, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Smolderen KG; Section of Cardiovascular Diseases, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Turner J; Section of Nephrology, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Schneider M; Section of Cardiovascular Diseases, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Llanos-Chea F; Section of Cardiovascular Diseases, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Mena-Hurtado C; Section of Cardiovascular Diseases, Yale New Haven Hospital, New Haven, Connecticut, USA.
Am J Nephrol ; 51(7): 527-533, 2020.
Article en En | MEDLINE | ID: mdl-32570255
BACKGROUND: There are limited data on outcomes of patients undergoing peripheral arterial disease (PAD) interventions who have comorbid CKD/ESRD versus those who do not have such comorbid condition. We performed a systematic review and meta-analysis to analyze outcomes in this patient population. METHODS: Five databases were searched for studies comparing outcomes of lower extremity PAD interventions for claudication and critical limb ischemia (CLI) in patients with CKD/ESRD versus non-CKD/non-ESRD from January 2000 to June 2019. RESULTS: Our study included 16 observational studies with 44,138 patients. Mean follow-up was 48.9 ± 27.4 months. Major amputation was higher with CKD/ESRD compared with non-CKD/non-ESRD (odds ratio [OR 1.97] [95% confidence interval [CI] 1.39-2.80], p = 0.001). Higher major amputations with CKD/ESRD versus non-CKD/non-ESRD were only observed when indication for procedure was CLI (OR 2.27 [95% CI 1.53-3.36], p < 0.0001) but were similar for claudication (OR 1.15 [95% CI 0.53-2.49], p = 0.72). The risk of early mortality was high with CKD/ESRD patients undergoing PAD interventions compared with non-CKD/non-ESRD (OR 2.55 [95% CI 1.65-3.96], p < 0.0001), which when stratified based on indication, remained higher with CLI (OR 3.14 [95% CI 1.80-5.48], p < 0.0001) but was similar with claudication (OR 1.83 [95% CI 0.90-3.72], p = 0.1). Funnel plot of included studies showed moderate bias. CONCLUSIONS: Patients undergoing lower extremity PAD interventions for CLI who also have comorbid CKD/ESRD have an increased risk of experiencing major amputations and early mortality. Randomized trials to understand outcomes of PAD interventions in this at-risk population are essential.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Enfermedad Arterial Periférica / Amputación Quirúrgica / Claudicación Intermitente / Isquemia Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Am J Nephrol Año: 2020 Tipo del documento: Article Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Enfermedad Arterial Periférica / Amputación Quirúrgica / Claudicación Intermitente / Isquemia Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Am J Nephrol Año: 2020 Tipo del documento: Article Pais de publicación: Suiza